Barclays analyst Gena Wang reiterated an Overweight rating and $27.00 price target on Vir Biotechnology (NASDAQ: VIR)The analyst comments "We ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE